Skip to main content
Equibles
AVR logo

AVR · Anteris Technologies Global Corp. · Metrics

Track AVR — free

Use AVR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AVR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.00 -0.01 (-0.17%) At close · Oct 22
Russell 2000 member Rebalance outlook locked
Market Cap
$582.80M
Shares
97.46M
Volume · Oct 22 2.1M Avg daily vol (3M) 1.01M

AVR metrics

82 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.00
Market cap
$582.80M

Price action

20 metrics
Price change (1W)
-5.7%
Price change (30D)
-26.2%
Price change (3M)
-26.7%
Price change (6M)
+8.5%
Price change (YTD)
+20.2%
Price change (1Y)
+2.0%
Trailing year
Price change (5Y)
—
52-week high
$10.57
52-week low
$3.38
Change from 52-week high
-43.2%
Change from 52-week low
+77.5%
Annualized volatility
63.8%
Annualized volatility (3M)
46.8%
Beta
1.3
RSI (14D)
27.2
Price vs SMA 50
-24.6%
Price vs SMA 200
-18.3%
Avg volume (3M)
1.01M
Relative volume
2.1
Average dollar volume
$7.79M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
97.46M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
148.7×
reciprocal yield 0.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
259.9×
reciprocal yield 0.4%
P / book
2.3
reciprocal yield 43.1%
FCF yield
-15.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-17.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
75.0%
Operating margin
-4,738.4%
Trailing 12 months
Net margin
-4,616.3%
Gross profit (TTM)
$1.68M
Operating profit (TTM)
−$106.23M
Net income (TTM)
−$103.50M
Trailing 12 months
Diluted EPS (TTM)
$-1.94
FCF margin
-3,934.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.04
Gross profit per diluted share (TTM)
$0.03
Operating profit per diluted share (TTM)
$-1.96
EBITDA per diluted share (TTM)
$-1.93
Net income per diluted share (TTM)
$-1.93
Operating cash flow per diluted share (TTM)
$-1.53
Free cash flow per diluted share (TTM)
$-1.57
Capital expenditures per diluted share (TTM)
$0.04
R&D per diluted share (TTM)
$1.41
Stock compensation per diluted share (TTM)
$0.16
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
+63.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.24M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+169.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-41.2%
Return on assets
-38.0%
Debt / equity
0.0
Current ratio
14.2
EBITDA (TTM)
−$104.50M
Free cash flow (TTM)
−$88.21M
Quick ratio
14.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$249.45M
Latest balance sheet
Cash & equivalents
$249.90M
Total assets
$272.51M
Total debt
$451,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$86.26M
Capital expenditures (TTM)
$1.95M
R&D (TTM)
$77.15M
SG&A (TTM)
$30.77M
Stock compensation (TTM)
$8.47M
R&D / revenue
3,441.1%
Stock compensation / revenue
377.8%

Ownership (13F)

9 metrics
13F filers
137
13F filer change QoQ
+9
Institutional ownership
66.9%
Conviction holders (share of 13F filers)
2.2%
Crowding (high-turnover and private-fund holders)
27.4%
Private-fund adviser ownership
21.0%
Active holders' share change QoQ
-1.4%
Holder tenure
5.5
Price vs estimated holder cost
+64.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.6%

Short interest

3 metrics
Short interest
6.8%
Latest settlement · 7.7 days to cover
Days to cover
7.7d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 2011514 CUSIP 03675P102 13F (30d) 11 filings 11 filers Visit website Investor relations